Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice

Daisuke Muraoka1,2, Meng Ling Moi3,4, Osamu Muto5,6

  • 1Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. d.muraoka@aichi-cc.jp.

NPJ Vaccines
|September 18, 2024
PubMed

Related Concept Videos